| Article ID | Journal | Published Year | Pages | File Type |
|---|---|---|---|---|
| 2543842 | Journal of the American Pharmacists Association | 2010 | 10 Pages |
Abstract
A growing body of clinical trial data suggest that aggressive combination antihypertensive therapy, including a RAAS blocker and CCB, may help reduce stroke incidence. Fixed-dose combination therapy is an important consideration in optimizing blood pressure control and patient adherence to therapy in stroke prevention.
Related Topics
Health Sciences
Medicine and Dentistry
Public Health and Health Policy
Authors
Robert L. (Professor),